| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tRNA-4-demethylwyosine synthase activity | 1.04e-05 | 2 | 65 | 2 | GO:0102521 | |
| GeneOntologyMolecularFunction | UDP-galactosyltransferase activity | 1.53e-04 | 32 | 65 | 3 | GO:0035250 | |
| GeneOntologyMolecularFunction | galactosyltransferase activity | 2.00e-04 | 35 | 65 | 3 | GO:0008378 | |
| GeneOntologyMolecularFunction | oxo-acid-lyase activity | 2.17e-04 | 7 | 65 | 2 | GO:0016833 | |
| GeneOntologyMolecularFunction | adenylate kinase activity | 3.70e-04 | 9 | 65 | 2 | GO:0004017 | |
| GeneOntologyMolecularFunction | carbon-carbon lyase activity | 8.07e-04 | 56 | 65 | 3 | GO:0016830 | |
| Domain | tRNA_wybutosine-synth | 1.19e-05 | 2 | 65 | 2 | IPR013917 | |
| Domain | Wyosine_form | 1.19e-05 | 2 | 65 | 2 | PF08608 | |
| Domain | VAST | 3.57e-05 | 3 | 65 | 2 | PS51778 | |
| Domain | DUF4782 | 3.57e-05 | 3 | 65 | 2 | IPR031968 | |
| Domain | DUF4782 | 3.57e-05 | 3 | 65 | 2 | PF16016 | |
| Domain | - | 1.54e-04 | 333 | 65 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.60e-04 | 335 | 65 | 7 | IPR015943 | |
| Domain | PH-BEACH_dom | 3.29e-04 | 8 | 65 | 2 | IPR023362 | |
| Domain | FLAVODOXIN_LIKE | 3.29e-04 | 8 | 65 | 2 | PS50902 | |
| Domain | Flavodoxin/NO_synth | 3.29e-04 | 8 | 65 | 2 | IPR008254 | |
| Domain | - | 3.29e-04 | 8 | 65 | 2 | 2.30.29.40 | |
| Domain | Flavdoxin-like | 3.29e-04 | 8 | 65 | 2 | IPR001094 | |
| Domain | PH_BEACH | 3.29e-04 | 8 | 65 | 2 | PS51783 | |
| Domain | Flavodoxin_1 | 3.29e-04 | 8 | 65 | 2 | PF00258 | |
| Domain | ARM-like | 3.49e-04 | 270 | 65 | 6 | IPR011989 | |
| Domain | - | 4.19e-04 | 42 | 65 | 3 | 3.20.20.70 | |
| Domain | rSAM | 4.23e-04 | 9 | 65 | 2 | IPR007197 | |
| Domain | Radical_SAM | 4.23e-04 | 9 | 65 | 2 | PF04055 | |
| Domain | BEACH_dom | 4.23e-04 | 9 | 65 | 2 | IPR000409 | |
| Domain | BEACH | 4.23e-04 | 9 | 65 | 2 | PS50197 | |
| Domain | Beach | 4.23e-04 | 9 | 65 | 2 | PF02138 | |
| Domain | - | 4.23e-04 | 9 | 65 | 2 | 1.10.1540.10 | |
| Domain | Beach | 4.23e-04 | 9 | 65 | 2 | SM01026 | |
| Domain | Aldolase_TIM | 4.81e-04 | 44 | 65 | 3 | IPR013785 | |
| Domain | Flavoprotein-like_dom | 5.27e-04 | 10 | 65 | 2 | IPR029039 | |
| Domain | Adenylat/UMP-CMP_kin | 5.27e-04 | 10 | 65 | 2 | IPR000850 | |
| Domain | - | 5.27e-04 | 10 | 65 | 2 | 3.40.50.360 | |
| Domain | WD40_repeat_dom | 5.78e-04 | 297 | 65 | 6 | IPR017986 | |
| Domain | ARM-type_fold | 1.15e-03 | 339 | 65 | 6 | IPR016024 | |
| Domain | GRAM | 1.39e-03 | 16 | 65 | 2 | SM00568 | |
| Domain | P-loop_NTPase | 2.56e-03 | 848 | 65 | 9 | IPR027417 | |
| Domain | GRAM | 2.63e-03 | 22 | 65 | 2 | PF02893 | |
| Domain | GRAM | 2.63e-03 | 22 | 65 | 2 | IPR004182 | |
| Domain | - | 4.22e-03 | 746 | 65 | 8 | 3.40.50.300 | |
| Domain | - | 7.47e-03 | 222 | 65 | 4 | 1.25.10.10 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 16162496 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 23007393 | ||
| Pubmed | ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. | 3.66e-06 | 2 | 67 | 2 | 24695436 | |
| Pubmed | Aster-dependent nonvesicular transport facilitates dietary cholesterol uptake. | 3.66e-06 | 2 | 67 | 2 | 37943936 | |
| Pubmed | Molecular architecture of the Bardet-Biedl syndrome protein 2-7-9 subcomplex. | 1.10e-05 | 3 | 67 | 2 | 31530639 | |
| Pubmed | Loss of TSC complex enhances gluconeogenesis via upregulation of Dlk1-Dio3 locus miRNAs. | 1.10e-05 | 3 | 67 | 2 | 31919282 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 21330826 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 36265896 | ||
| Pubmed | Ribonucleome analysis identified enzyme genes responsible for wybutosine synthesis. | 2.19e-05 | 4 | 67 | 2 | 17150819 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 10215863 | ||
| Pubmed | 5.46e-05 | 6 | 67 | 2 | 30220461 | ||
| Pubmed | BBS mutations modify phenotypic expression of CEP290-related ciliopathies. | 7.63e-05 | 7 | 67 | 2 | 23943788 | |
| Pubmed | Complex protein interactions within the human polyadenylation machinery identify a novel component. | 7.63e-05 | 7 | 67 | 2 | 10669729 | |
| Pubmed | Protein interaction perturbation profiling at amino-acid resolution. | 7.63e-05 | 7 | 67 | 2 | 29039417 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 9.63e-05 | 1201 | 67 | 10 | 35696571 | |
| Pubmed | The human adenylate kinase 9 is a nucleoside mono- and diphosphate kinase. | 1.02e-04 | 8 | 67 | 2 | 23416111 | |
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 17903303 | ||
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 7590244 | ||
| Pubmed | 1.12e-04 | 128 | 67 | 4 | 30995482 | ||
| Pubmed | The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. | 1.30e-04 | 9 | 67 | 2 | 9002523 | |
| Pubmed | Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. | 1.30e-04 | 9 | 67 | 2 | 20062062 | |
| Pubmed | Atlas of gene expression in the developing kidney at microanatomic resolution. | 1.58e-04 | 54 | 67 | 3 | 19000842 | |
| Pubmed | A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and Smoothened. | 1.63e-04 | 10 | 67 | 2 | 22072986 | |
| Pubmed | Temporal expression pattern of Bardet-Biedl syndrome genes in adipogenesis. | 1.63e-04 | 10 | 67 | 2 | 17379567 | |
| Pubmed | A BBSome subunit links ciliogenesis, microtubule stability, and acetylation. | 1.63e-04 | 10 | 67 | 2 | 19081074 | |
| Pubmed | 1.63e-04 | 10 | 67 | 2 | 17574030 | ||
| Pubmed | 1.63e-04 | 10 | 67 | 2 | 22139371 | ||
| Pubmed | 1.99e-04 | 11 | 67 | 2 | 24550735 | ||
| Pubmed | 1.99e-04 | 11 | 67 | 2 | 25552655 | ||
| Pubmed | 2.81e-04 | 13 | 67 | 2 | 22500027 | ||
| Pubmed | 3.78e-04 | 15 | 67 | 2 | 22922713 | ||
| Pubmed | BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly. | 3.78e-04 | 15 | 67 | 2 | 20080638 | |
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 10580128 | ||
| Pubmed | Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D. | 4.88e-04 | 17 | 67 | 2 | 22041458 | |
| Pubmed | Transcriptional regulatory network of SOX4 during myoblast differentiation. | 6.12e-04 | 19 | 67 | 2 | 25969425 | |
| Pubmed | Hypoxia-Regulated lncRNA USP2-AS1 Drives Head and Neck Squamous Cell Carcinoma Progression. | 6.12e-04 | 19 | 67 | 2 | 36359803 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 7.19e-04 | 774 | 67 | 7 | 15302935 | |
| Pubmed | 7.24e-04 | 1014 | 67 | 8 | 32416067 | ||
| Pubmed | 7.50e-04 | 21 | 67 | 2 | 20708005 | ||
| Pubmed | PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation. | 9.82e-04 | 24 | 67 | 2 | 24710276 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.12e-03 | 1353 | 67 | 9 | 29467282 | |
| Pubmed | 1.24e-03 | 415 | 67 | 5 | 16385451 | ||
| Pubmed | 1.24e-03 | 27 | 67 | 2 | 20301537 | ||
| Pubmed | 1.24e-03 | 27 | 67 | 2 | 21510876 | ||
| Pubmed | 1.31e-03 | 111 | 67 | 3 | 12508121 | ||
| Pubmed | The basement membrane of hair follicle stem cells is a muscle cell niche. | 1.34e-03 | 28 | 67 | 2 | 21335239 | |
| Pubmed | Genetics of rheumatoid arthritis contributes to biology and drug discovery. | 1.34e-03 | 112 | 67 | 3 | 24390342 | |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 1.48e-03 | 254 | 67 | 4 | 28431233 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 1.19e-04 | 8 | 38 | 2 | 1122 | |
| GeneFamily | Adenylate kinases | 1.53e-04 | 9 | 38 | 2 | 356 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.53e-04 | 9 | 38 | 2 | 1230 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 3.31e-04 | 13 | 38 | 2 | 1146 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 8.81e-04 | 21 | 38 | 2 | 980 | |
| GeneFamily | WD repeat domain containing | 2.16e-03 | 262 | 38 | 4 | 362 | |
| Coexpression | GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN | 1.17e-05 | 198 | 67 | 6 | M7139 | |
| Coexpression | GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN | 1.21e-05 | 199 | 67 | 6 | M3313 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.24e-05 | 200 | 67 | 6 | M9358 | |
| Coexpression | GSE27786_BCELL_VS_NKTCELL_DN | 1.24e-05 | 200 | 67 | 6 | M4809 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 9.38e-05 | 417 | 67 | 7 | M39224 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 1.44e-04 | 195 | 67 | 5 | M7397 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN | 1.51e-04 | 197 | 67 | 5 | M8386 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 1.51e-04 | 197 | 67 | 5 | M7403 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP | 1.54e-04 | 198 | 67 | 5 | M7459 | |
| Coexpression | GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP | 1.54e-04 | 198 | 67 | 5 | M4432 | |
| Coexpression | GSE14308_TH2_VS_NATURAL_TREG_DN | 1.58e-04 | 199 | 67 | 5 | M3369 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 1.62e-04 | 200 | 67 | 5 | M9354 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.62e-04 | 200 | 67 | 5 | M9317 | |
| Coexpression | GSE30083_SP1_VS_SP2_THYMOCYTE_DN | 1.62e-04 | 200 | 67 | 5 | M5024 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN | 1.62e-04 | 200 | 67 | 5 | M6687 | |
| Coexpression | GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP | 1.62e-04 | 200 | 67 | 5 | M9734 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP | 1.62e-04 | 200 | 67 | 5 | M4353 | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte-Alox5+_lymphocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-07 | 177 | 67 | 6 | b7cfa3776f58377e35830780650d236b5cceecee | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-07 | 177 | 67 | 6 | 1730e640986e50943bd781b7d949bcc5b7c12dde | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 176 | 67 | 5 | 096cbcefd9dcbaee660568998ba210253b58501e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 176 | 67 | 5 | 90198fb79e8b08e9e7df538cbc05ad7141e78517 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.45e-06 | 179 | 67 | 5 | e7045e27f0eb88f552b31c04b56d78e5ccd7a36c | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.95e-06 | 190 | 67 | 5 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.02e-05 | 191 | 67 | 5 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.07e-05 | 193 | 67 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.24e-05 | 94 | 67 | 4 | d78535a7a0fda7299b01912333b944dc5e0a0361 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.24e-05 | 94 | 67 | 4 | dfc3f7977b9df433009d1d2d465b64a2de5806e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 199 | 67 | 5 | 0d6463e368fd611a17327322413fad145f3c7f32 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 199 | 67 | 5 | 036776a03fdd181e51cc655ed99331eec9c63f39 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 200 | 67 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 200 | 67 | 5 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 200 | 67 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 200 | 67 | 5 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.92e-05 | 105 | 67 | 4 | 76b73bc9236030e0703868fa8f7ecee2affe565b | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.92e-05 | 105 | 67 | 4 | bfd3395c51a0e868aa92eac4e929de59a3fe8b50 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.92e-05 | 105 | 67 | 4 | 96566c83999aa625c84a4ed18a6df9daa99f9578 | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 5.13e-05 | 135 | 67 | 4 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 8.99e-05 | 156 | 67 | 4 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 8.99e-05 | 156 | 67 | 4 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.68e-05 | 159 | 67 | 4 | 08a1cd71eac4322fb313324f74fe8e37998f2d7d | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.68e-05 | 159 | 67 | 4 | c0e55f25271f788c08fa4b95186501fc27b2ec39 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.68e-05 | 159 | 67 | 4 | 9bdfa7f5aa7753fe25b787bd43d694b6093d77eb | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.92e-05 | 160 | 67 | 4 | e4516b093003275084fc327d1597394a436754eb | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.92e-05 | 160 | 67 | 4 | 0a507e3d59d7f744d0201a531ea84fa97a68aedb | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 162 | 67 | 4 | b877b232f0a879a9058d81ad4730e7846484b7c3 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 162 | 67 | 4 | 7384a4dd38ed68ca02a72df6deff4d34c9694ce1 | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 162 | 67 | 4 | 04ccd3d216f8f41afd3434a61264f03d6324db35 | |
| ToppCell | Severe-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass | 1.25e-04 | 170 | 67 | 4 | 5788e1158fde036937d41708e9db3222ca351eb1 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.28e-04 | 171 | 67 | 4 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 172 | 67 | 4 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 172 | 67 | 4 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 173 | 67 | 4 | 0a355386210a13927ea29b10b64cb059459952d4 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 173 | 67 | 4 | 6e92983d9f8a2a37f23e60a0d5bb1738217897bc | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 173 | 67 | 4 | 3678b300cad4effd7f49bfb043305ed512693848 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 173 | 67 | 4 | 4c788c1dad1da495b3b5c10f95e779848dfe85dc | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 174 | 67 | 4 | aae7ab9df5a78716034ddfd5bd47adc69912d624 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 174 | 67 | 4 | d9489c4196d103ead8cb6279492bbe563a222e45 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 175 | 67 | 4 | 1b3510e9078eec7cfc5805043e435e9e5e0f0877 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-04 | 177 | 67 | 4 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 178 | 67 | 4 | be4976bbfd9ebbc568155ede99a07670c43aa372 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-04 | 178 | 67 | 4 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 178 | 67 | 4 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 178 | 67 | 4 | 910f8bea19d335455aba24e6a07b4834b709db5d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 178 | 67 | 4 | 91bf3c7c05d2e67ee590389a1b36c517d0ed7ebf | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 178 | 67 | 4 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 179 | 67 | 4 | 716856b2c7c660bf5ce00e63efeda6ed121f2baa | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 179 | 67 | 4 | 30efe1f0394c0edb27b91890b5c4637b73cbc5ec | |
| ToppCell | Control-Lymphocytic_NKT-T_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-04 | 179 | 67 | 4 | d892d9496f1c33e23312092591eb2e968e736f7d | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 179 | 67 | 4 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 180 | 67 | 4 | b28363626f4d2a552abde3434cc1df2e2121aba5 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-04 | 180 | 67 | 4 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-04 | 180 | 67 | 4 | d6e69ac2bd619557ef62ada684c37a44dc4e3f41 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 180 | 67 | 4 | 67b062f2ef7e20f392e00c646f4985c415d40de9 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-04 | 181 | 67 | 4 | a4347ae554e6dcf03c7001a2b69332b377c7c034 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-04 | 183 | 67 | 4 | c9cb69377883d4579c608ec8b265153fe5290e67 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.66e-04 | 183 | 67 | 4 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 184 | 67 | 4 | cdacb61878e0824b8416bf365d89965797208359 | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.70e-04 | 184 | 67 | 4 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 1.73e-04 | 185 | 67 | 4 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 185 | 67 | 4 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 185 | 67 | 4 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 186 | 67 | 4 | e152bdd837366e3e0b8bcfdb4d53f0685f2e803a | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 187 | 67 | 4 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.81e-04 | 187 | 67 | 4 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | COVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.84e-04 | 188 | 67 | 4 | 15484c05cb496cd98ed3f79a6134c5cec8f09a4d | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 189 | 67 | 4 | 1b84ff069e95ff113d8d861f38e07a08eb3d7070 | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.88e-04 | 189 | 67 | 4 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 189 | 67 | 4 | f4b8415edf538ce152703ad2c07be96af12b1acd | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 1.92e-04 | 190 | 67 | 4 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.96e-04 | 191 | 67 | 4 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.96e-04 | 191 | 67 | 4 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 1.96e-04 | 191 | 67 | 4 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.00e-04 | 192 | 67 | 4 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 193 | 67 | 4 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 193 | 67 | 4 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 194 | 67 | 4 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 194 | 67 | 4 | 6385cf2a1529d2e225e407c33da959fccaaca3a4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 194 | 67 | 4 | 0866ab6792cee274a71991d5c37a37f574ff446e | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 2.08e-04 | 194 | 67 | 4 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-04 | 195 | 67 | 4 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | proximal-Hematologic-Natural_Killer_T-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-04 | 195 | 67 | 4 | 4d7c2c4d0130c2d46877ff6dd4584525d8f74daf | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.12e-04 | 195 | 67 | 4 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | proximal-3-Hematologic-Natural_Killer_T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-04 | 195 | 67 | 4 | 93093545bb23d2619ace029a52cffa1f673a0c2a | |
| ToppCell | proximal-Hematologic-Natural_Killer_T|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-04 | 195 | 67 | 4 | 3944e4800f5d904d4efa401ce8913ec0e0781211 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 2.12e-04 | 195 | 67 | 4 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-04 | 195 | 67 | 4 | fca958f73de450ef813444d3dc590353f1c55326 | |
| ToppCell | medial-Hematologic-CD8+_Memory/Effector_T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-04 | 196 | 67 | 4 | 252e15a4ea54d872c5b910711941dcdf359c0492 | |
| ToppCell | medial-Hematologic-CD8+_Memory/Effector_T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-04 | 196 | 67 | 4 | caef28955269f4f6fb323a74b6b73cff8db11272 | |
| ToppCell | medial-2-Hematologic-CD8+_Memory/Effector_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-04 | 196 | 67 | 4 | e401d1683a13f2636e8fc0e22428a6a3653a1521 | |
| ToppCell | Severe-Lymphoid-T-CCR7+_T|Severe / Condition, Lineage, Cell class and cell subclass | 2.20e-04 | 197 | 67 | 4 | 0489e0b08f3c3ef90b166ea2f26a0b2b12bd2077 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-04 | 197 | 67 | 4 | eebf4c3e71efc17672801649eed1bf158b2a88e5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 197 | 67 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | mild_COVID-19-B_intermediate|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.20e-04 | 197 | 67 | 4 | f669500120646f69355a6f920b892a6f2faeab63 | |
| ToppCell | mild_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 2.20e-04 | 197 | 67 | 4 | e909b898b7458071f176b6c04356ea3540589153 | |
| ToppCell | Severe_COVID-19-T/NK-CD4+_T_1|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.25e-04 | 198 | 67 | 4 | bc6b983fdb9547ef8a9e693bc15fced1b73e101f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.25e-04 | 198 | 67 | 4 | 8a7897d98f5296745d9005a7cd777f0a2f78000d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.25e-04 | 198 | 67 | 4 | fc8099bce80d84b29bdcc87064d4d8375dddfa0f | |
| Computational | Neighborhood of SNRK | 1.36e-04 | 28 | 39 | 3 | GNF2_SNRK | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.08e-06 | 182 | 67 | 7 | 1043_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.77e-06 | 196 | 67 | 7 | 1684_UP | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 1.50e-05 | 180 | 67 | 6 | 5202_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 2.23e-05 | 193 | 67 | 6 | 4113_DN | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 6019_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; PC3; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 7296_DN | |
| Drug | AC1L1IZ2 | 3.09e-05 | 304 | 67 | 7 | CID000004795 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 2.86e-05 | 4 | 65 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 1.70e-04 | 9 | 65 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 2.59e-04 | 11 | 65 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 4.27e-04 | 14 | 65 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 6.36e-04 | 17 | 65 | 2 | C2936862 | |
| Disease | Bardet-Biedl syndrome | 7.15e-04 | 18 | 65 | 2 | cv:C0752166 | |
| Disease | Ciliopathies | 1.86e-03 | 110 | 65 | 3 | C4277690 | |
| Disease | intellectual disability (is_implicated_in) | 2.00e-03 | 30 | 65 | 2 | DOID:1059 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ENFELINHDVVEPLY | 136 | Q8NBZ7 | |
| QHDLVPHYYVESIAD | 656 | Q6ZT62 | |
| KPVDAEALELHDYHD | 336 | Q15059 | |
| FLIPEYHCILEEADH | 641 | Q8IWZ6 | |
| LVDSEVLTHDVPYHD | 416 | Q8IYS0 | |
| NHHLEPEEVLKYSEF | 331 | Q9BRK5 | |
| FDHLEPEELSEHLTY | 201 | O95267 | |
| PNESIDDEHLLIQHY | 3461 | P11532 | |
| IFHDVDHIPESDRNY | 231 | O43286 | |
| ELEHEFYELEPLASH | 1186 | Q96F81 | |
| YVIDAEVLTHDVPYH | 461 | Q3KR37 | |
| YPAHPQDFHEVEDLI | 126 | P30039 | |
| EDLENIEGLHHLYEI | 181 | Q6IN85 | |
| FVFDHDLVLPEYVVE | 606 | Q6ZRR7 | |
| ELVHRFQEYIDAHPE | 76 | Q13572 | |
| LVHHFEIDVDIFEPQ | 186 | P19827 | |
| VDFLIIYIEEAHPSD | 191 | P55073 | |
| AHKQFDHYLEELILP | 231 | Q7Z5Y7 | |
| AYLPLHVHEEEGIVV | 316 | Q3SXM0 | |
| HSLLERYPEILEAEH | 661 | Q5H9U9 | |
| RYPEILEAEHHQYIA | 666 | Q5H9U9 | |
| HVDQELLIYEAFPHD | 866 | Q10570 | |
| IEDPELIIKHFHEAY | 231 | Q9P1W3 | |
| EYVIPVHYDLLIHAN | 56 | Q9NZ08 | |
| LKELEVPHFHHELVY | 351 | Q53EL6 | |
| PEYNFLLHLDHVEFK | 866 | Q13370 | |
| HEAVHTEPLDELYEA | 81 | Q96G04 | |
| LEVHFVEHYREIFDI | 931 | P36776 | |
| SIIPILYDHEHATFE | 371 | Q6X4W1 | |
| YAHPFLEELLITFDH | 201 | A6NDL7 | |
| EHPSLELLHLYFNEL | 861 | Q86UT6 | |
| EVGPLVEHIYELHNI | 816 | P53708 | |
| PLQEYFELIDHHFEL | 641 | Q3SYG4 | |
| QDFLHEIYFLPDHPE | 1246 | Q13535 | |
| HFPEVVQHEEFILLS | 161 | Q53G59 | |
| VEHTFEEIKPLYEHL | 226 | Q9BYF1 | |
| YDTTNHFLPLDELEH | 291 | Q12794 | |
| YGHILTPEEIEDHVE | 1031 | Q9NYC9 | |
| ENHPVIRTLYDHVDE | 161 | Q05048 | |
| PQYEVLIVDEVHERH | 271 | Q14147 | |
| SLHELEDYIHNIEPV | 76 | Q5VWG9 | |
| EILHHLVQRPEDYLE | 221 | Q5TCS8 | |
| LEFKDLVQLTHYHDP | 1556 | O75691 | |
| DYQDLFPPHHQEVEV | 751 | A5PLK6 | |
| AIFHELHVDPDLYTL | 221 | Q8IVB4 | |
| DQEILEAELHFPAHV | 241 | Q9P1W9 | |
| EYHKARDELPFLHEV | 46 | Q7Z333 | |
| PISEDEQELHYAVLH | 416 | O43699 | |
| HLEDLAYLDEQRHTP | 276 | Q9HCD6 | |
| DELNADHPFIYIIRH | 346 | P36952 | |
| EVHLVQFHEPDIYNY | 36 | Q92854 | |
| HDLVPHYYVESIADL | 276 | Q96GD0 | |
| HITDQVHLYPIDDVY | 321 | Q9NY97 | |
| YEFEIALVLKHHPDD | 161 | Q8N999 | |
| EPHDKHLLDRINEYV | 66 | Q92574 | |
| APYELHLSLFEHFIE | 1511 | Q8IZQ1 | |
| FIPYLHLVAHLQDLD | 231 | Q7RTY0 | |
| EDTLAYALVVHHPQD | 171 | Q96AN5 | |
| HFKDLLLHEPYVDLV | 161 | O76061 | |
| LLEALVFELHYVPHE | 451 | Q6ZS81 | |
| DFLAHHVHIPEVYLI | 1706 | Q6ZS81 | |
| CHELFEDLPLLYEHE | 851 | Q8IZM8 | |
| EDLPLLYEHEAQHYL | 856 | Q8IZM8 | |
| HTELVFHYVVHELVP | 111 | Q9H777 | |
| IEEQHDLDHYLFPIV | 6 | Q8IYL9 | |
| ELEDRPELQHVYLHK | 586 | P49754 | |
| DEIEEHNIKIYHLPD | 201 | Q15019 | |
| YPDLAEVHALEALIH | 416 | Q6PGP7 | |
| DLIPEYEIACEHEHS | 636 | Q9NV66 | |
| ELLLHQRDHTEEKPY | 221 | Q16600 | |
| LLRYLQEAFHVEPEE | 81 | Q70J99 | |
| VDLIPEYEIACEHEH | 571 | Q6NUM6 | |
| FNYFDELEIHPIHID | 571 | Q96M32 |